iRhythm Technologies Inc
NASDAQ:IRTC
Intrinsic Value
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. [ Read More ]
The intrinsic value of one
IRTC
stock under the Base Case scenario is
107.71
USD.
Compared to the current market price of 114.11 USD,
iRhythm Technologies Inc
is
Overvalued by 6%.
IRTC's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
IRTC or that its price is influenced by factors unrelated to fundamentals.
iRhythm Technologies Inc's market capitalization is 3.5B USD.
IRTC stock price is 114.11 USD.
IRTC stock (107.71 USD) is 6% less than its price (114.11 USD).
IRTC. Open DCF Valuation
IRTC stock (107.71 USD) is 6% less than its price (114.11 USD). Open Relative Valuation
IRTC has upside potential of 24% compared to the average analyst price target.
Open Wall St Estimates
IRTC's ROIC (Return on Invested Capital) has decreased in the last 3 years from -34% to -38%, and is approaching profitability.
IRTC's Revenue has grown by 20% over the past 12 months.
IRTC's Revenue is forecast to grow at a rate of 19% per year over the next 3 years.
IRTC's Revenue has been growing by an exceptional 23% per year for the last 3 years.
IRTC's ROE (Return on Equity) has significantly decreased in the last 3 years from -29% to -55%, and is approaching profitability.
IRTC's long-term assets (433m USD) exceed its long-term liabilties (223m USD).
IRTC's short-term assets (231m USD) exceed its short-term liabilties (107m USD).
IRTC has negative Operating Income for the last twelve months.
IRTC has negative Net Income for the last twelve months.
IRTC's ROE (Return on Equity) for the past 12 months is negative and is equal to -55%.
IRTC's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -38%.
IRTC has positive Gross Profit for the last twelve months.
IRTC has negative Free Cash Flow for the last twelve months.
IRTC's D/E (Debt to Equity) is very low and is equal to 0.17.
IRTC has negative Net Debt. This means that the company has more cash and short-term investments (134m USD) than debt (35m USD).
IRTC has negative three-year average ROE (Return on Equity): -39%. The company is not efficient at transforming stockholders' equity into net income.
IRTC has negative three-year average ROIC (Return on Invested Capital): -41%. The company is not efficient at using invested capital to generate operating income.
IRTC's Altman Z-Score is very high and is equal to 7.19.
IRTC doesn't generate enough operating income (-98m USD) to safely cover interest payments on its debt (3m USD).
Valuation Backtest
iRhythm Technologies Inc
Run backtest to discover the historical profit from buying and selling
IRTC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
iRhythm Technologies Inc
Balance Sheet Decomposition
iRhythm Technologies Inc
| Current Assets | 230.8m |
| Cash & Short-Term Investments | 133.8m |
| Receivables | 61.5m |
| Other Current Assets | 35.6m |
| Non-Current Assets | 202.3m |
| PP&E | 153.4m |
| Intangibles | 862k |
| Other Non-Current Assets | 48m |
| Current Liabilities | 107.4m |
| Accounts Payable | 5.5m |
| Accrued Liabilities | 98.5m |
| Other Current Liabilities | 3.3m |
| Non-Current Liabilities | 115.7m |
| Long-Term Debt | 35m |
| Other Non-Current Liabilities | 80.7m |
Earnings Waterfall
iRhythm Technologies Inc
|
Revenue
|
492.7m
USD
|
|
Cost of Revenue
|
-160.9m
USD
|
|
Gross Profit
|
331.8m
USD
|
|
Operating Expenses
|
-430m
USD
|
|
Operating Income
|
-98.2m
USD
|
|
Other Expenses
|
-25.2m
USD
|
|
Net Income
|
-123.4m
USD
|
Free Cash Flow Analysis
iRhythm Technologies Inc
What is Free Cash Flow?
IRTC Profitability Score
Profitability Due Diligence
iRhythm Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
iRhythm Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
IRTC Solvency Score
Solvency Due Diligence
iRhythm Technologies Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
iRhythm Technologies Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IRTC Price Targets Summary
iRhythm Technologies Inc
According to Wall Street analysts, the average 1-year price target for
IRTC
is 141.89 USD
with a low forecast of 133.32 USD and a high forecast of 173.25 USD.
Ownership
IRTC Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
IRTC Price
iRhythm Technologies Inc
| Average Annual Return | 40.08% |
| Standard Deviation of Annual Returns | 130.11% |
| Max Drawdown | -84% |
| Market Capitalization | 3.5B USD |
| Shares Outstanding | 30 702 000 |
| Percentage of Shares Shorted | 8.26% |
Company Profile
iRhythm Technologies Inc
Country
Industry
Market Cap
Dividend Yield
Description
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. The company is headquartered in San Francisco, California and currently employs 1,700 full-time employees. The company went IPO on 2016-10-20. The firm has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The firm's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.
Contact
IPO
Employees
Officers
The intrinsic value of one
IRTC
stock under the Base Case scenario is
107.71
USD.
Compared to the current market price of 114.11 USD,
iRhythm Technologies Inc
is
Overvalued by 6%.
You don't have any saved screeners yet
